Related Experiment Videos
Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue
1Committee on Vascular Biology, Scripps Research Institute, La Jolla, CA 92037.
Abstract:
Type 1 plasminogen activator inhibitor (PAI-1) may be markedly increased in the plasma of patients with endotoxemia and/or renal disease. To investigate renal PAI-1 production during acute endotoxemia, a murine model system was used. Mice were injected with either saline alone or saline containing 50 micrograms endotoxin, and sacrificed 3 hours later and their tissues analyzed for PAI-1 messenger RNA (mRNA) and antigen. Northern blot analysis confirmed that the level of renal PAI-1 mRNA was greatly increased in the endotoxemic mice relative to the saline controls. In situ hybridization was then performed to determine the cellular localization of PAI-1 mRNA within the renal tissues. In the control kidneys, low levels of PAI-1 mRNA were detected in the renal papilla and in the muscular walls of renal arteries. However, in the endotoxemic mice, an intense hybridization signal for PAI-1 mRNA was observed in glomerular and peritubular cells. These cells also stained positively for von Willebrand factor antigen, an endothelial cell-specific marker. The PAI-1 mRNA hybridization signal could further be observed in peritubular endothelial cells in the medulla and in endothelial cells of veins and arteries throughout the kidney. Immunochemical analysis revealed that PAI-1 antigen co-localized to the cytoplasm of cells expressing PAI-1 mRNA. This study provides the first direct evidence that PAI-1 is induced in endothelial cells of the kidney during endotoxemia in vivo and suggests a role for PAI-1 in the pathogenesis of renal disease.
Insights
Acute endotoxemia significantly increases renal Type 1 plasminogen activator inhibitor (PAI-1) production in endothelial cells. This finding suggests PAI-1 plays a role in endotoxemia-induced kidney disease pathogenesis.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Type 1 plasminogen activator inhibitor (PAI-1) levels are elevated in patients with endotoxemia and renal disease.
- The source of renal PAI-1 during acute endotoxemia remains unclear.
Purpose of the Study:
- To investigate the production and cellular localization of renal PAI-1 during acute endotoxemia in a murine model.
- To determine if endotoxemia induces PAI-1 expression in kidney cells.
Main Methods:
- Murine model of acute endotoxemia induced by endotoxin injection.
- Analysis of renal PAI-1 messenger RNA (mRNA) and antigen using Northern blot, in situ hybridization, and immunochemical analysis.
- Identification of cell types expressing PAI-1 mRNA and antigen using endothelial cell markers.
Main Results:
- Endotoxemic mice showed significantly increased renal PAI-1 mRNA levels compared to controls.
- PAI-1 mRNA and antigen were localized to glomerular and peritubular endothelial cells in endotoxemic kidneys.
- PAI-1 expression was induced in endothelial cells throughout the kidney during endotoxemia.
Conclusions:
- This study provides the first in vivo evidence that PAI-1 is induced in renal endothelial cells during acute endotoxemia.
- The findings suggest a potential role for PAI-1 in the pathogenesis of endotoxemia-associated kidney injury.